Table 1.
Group data for blood glucose (mmol/L) for the control group and HBOT group.
Table 2.
Group data for body weight (gram) for the control group and HBOT group.
Figure 1.
Macroscopic images of control and HBOT wounds at post-wounding days 7 and 29.
Figure 2.
Histological staining of control and HBOT wounds at post-wounding days 7 and 29.
A–D) H&E staining. E–H) CD34 immunohistochemistry. I+J) CD68 immunohistochemistry.
Figure 3.
The effect of HBOT on blood flow, oxygen saturation of the hemoglobin at the venous end of the capillaries (SO2), and the quantity of hemoglobin in the micro-blood vessels (rHB).
Effects were measured, in control skin and at the wound edge in control and HBOT animals, approximately 20 hours after the last HBOT session. Data are presented as means ± SEM. P-values indicate differences between the respective control group and HBOT group. AU = artificial units.
Figure 4.
The effect of HBOT on blood flow, oxygen saturation of the hemoglobin at the venous end of the capillaries (SO2), and the quantity of hemoglobin in the micro blood vessels (rHB).
Effects were measured in control and HBOT animals, approximately 20 hours after the last HBOT session, and expressed as a percentage of the values of non-wounded skin in the respective animal. Data are presented as means ± SEM. P-values indicate differences between the respective control group and the HBOT group.
Figure 5.
Ratio of the skin breaking strength of normal skin and wounded skin in diabetic rats at day 29 post wounding.
Data are presented as means ± SEM. P-values indicate differences between the control group and the HBOT group.